Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omalizumab is effective in nonautoimmune urticaria.
Ferrer M, Gamboa P, Sanz ML, Goikoetxea MJ, Cabrera-Freitag P, Javaloyes G, Berroa F, Kaplan AP. Ferrer M, et al. J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11. J Allergy Clin Immunol. 2011. PMID: 21315432 No abstract available.
Pru p 3 acts as a strong sensitizer for peanut allergy in Spain.
Javaloyes G, Goikoetxea MJ, García Nuñez I, Aranda A, Sanz ML, Blanca M, Diaz Perales A, da Souza J, Esparza I, del Pozo V, Blazquez AB, Scheurer S, Vieths S, Ferrer M. Javaloyes G, et al. Among authors: ferrer m. J Allergy Clin Immunol. 2012 Dec;130(6):1432-4.e3. doi: 10.1016/j.jaci.2012.08.038. Epub 2012 Oct 12. J Allergy Clin Immunol. 2012. PMID: 23069486 No abstract available.
Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles.
De S Rebouças J, Irache JM, Camacho AI, Gastaminza G, Sanz ML, Ferrer M, Gamazo C. De S Rebouças J, et al. Among authors: ferrer m. Clin Vaccine Immunol. 2014 Aug;21(8):1106-12. doi: 10.1128/CVI.00359-14. Epub 2014 Jun 4. Clin Vaccine Immunol. 2014. PMID: 24899075 Free PMC article.
Pomegranate ( Punica granatum L.) expresses several nsLTP isoforms characterized by different immunoglobulin E-binding properties.
Bolla M, Zenoni S, Scheurer S, Vieths S, San Miguel Moncin Mdel M, Olivieri M, Antico A, Ferrer M, Berroa F, Enrique E, Avesani L, Marsano F, Zoccatelli G. Bolla M, et al. Among authors: ferrer m. Int Arch Allergy Immunol. 2014;164(2):112-21. doi: 10.1159/000362761. Epub 2014 Jun 17. Int Arch Allergy Immunol. 2014. PMID: 24941918
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial.
Gastaminza G, Azofra J, Nunez-Cordoba JM, Baeza ML, Echechipía S, Gaig P, García BE, Labrador-Horrillo M, Sala-Cunill A, Brescó MS, Beristain A, Quiñones D, Donado CD, Zubeldia JM, Ferrer M. Gastaminza G, et al. Among authors: ferrer m. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1599-1609.e1. doi: 10.1016/j.jaip.2018.12.025. Epub 2019 Jan 15. J Allergy Clin Immunol Pract. 2019. PMID: 30654196 Clinical Trial.
2,093 results